Home » Newsletters » BioWorld

BioWorld

Feb. 22, 1994

View Archived Issues

MARYLAND BILL PROPOSES BANNING HUMAN EMBRYO CLONING

ONCOR SELLS OVERALLOTED SHARES

PROCEPT UNDERWRITERS EXERCISE OPTION

HOECHST TO TEST CORTECS' PIG ANTI-DIARRHEAL

ALLODERM ENTERS CLINICALS FOR VENOUS ULCERS

PROCYTE UNDERWRITERS EXERCISE OPTION

DYNAGEN AMENDS PUBLIC OFFERING

BTG PULLS HEPANDRIN NDA

SYNERGEN'S NET LOSS DOUBLES FOR YEAR

ALLELIX RAISES $10.1M IN WARRANTS TRANSACTION

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...